Humoral Immunity Disorders Associated with Antibody Deficit
By LabMedica International staff writers Posted on 16 Jul 2018 |

Image: The BN ProSpec chemistry analyzer is a dedicated, compact system that offers a consolidated menu of specialty and routine reagents for reliable plasma protein testing (Photo courtesy of Siemens Healthcare).
Primary Immunodeficiencies (PID) are a heterogeneous group of diseases and they are rare diseases, but not as rare as once thought, with approximately 400 new PID cases are diagnosed annually in the USA.
Most common among PIDs are disorders of the humoral response associated with deficiency of antibodies, a heterogeneous group of proteins present in the body fluids of all vertebrates and characterized by a common pattern of construction. The most important of these are immunoglobulins (Ig) of the IgG class which account for about 75% of all immunoglobulins contained in serums.
Scientists at the Wroclaw Medical University (Wroclaw, Poland) analyzed the structure of patients group according to difference between total IgG and sum of the IgG subclasses and to determine factors affecting the level of this difference. This study was based on data collected from 670 children referred to the Department of Clinical Immunology and Pediatrics in order to diagnose the immune disorders. The median age of patients was 4.2 years with 421 males (62.8%) and 249 females (37.2%).
For all children the levels of the total of immunoglobulins IgG and of the IgG subclasses (IgG1, IgG2, IgG3, and IgG4) were determined. The group of children was divided into subgroups according to gender, age (under 6 years of age, 6.5 to 12 years, and 12 to18 years), and IgG abnormality (below the normal range, normal and above the normal range). The immunoturbidimetric method utilizing the ARCHITECT cSystem was used for total IgG determination. In contrast, IgG subclass levels were measured by the nephelometric method with the use of a BN ProSpec chemistry analyzer.
The scientists found for 80 patients IgG was below the normal range, for 496 patients IgG was normal, and for 73 patients IgG was above the normal range (12.3, 76.5 and 11.2%, respectively). The group of 80 patients with Total IgG deficiency can be divided according to the medical history into three clinical subgroups: recurrent respiratory tract infections (RRT), primary immunodeficiency (PID) and transient hypogammaglobulinemia of infancy (THI). Analyzing IgG abnormality groups, it was concluded that for the population with IgG greater than IgG sum, there is a lower proportion of patients with IgG below normal range than with IgG normal or above normal range.
The authors concluded that determination of serum immunoglobulin levels is an increasingly available and relatively inexpensive laboratory test performed not only in specialized departments but also in primary care. Assessment of IgG levels as well as IgA and IgM is one of the fundamental studies on the function of the immune system. The indications for their markings are very different and primarily include diagnostics for primary and secondary immunodeficiencies. The study was published on June 27, 2018, in the journal BMC Immunology.
Related Links:
Wroclaw Medical University
Most common among PIDs are disorders of the humoral response associated with deficiency of antibodies, a heterogeneous group of proteins present in the body fluids of all vertebrates and characterized by a common pattern of construction. The most important of these are immunoglobulins (Ig) of the IgG class which account for about 75% of all immunoglobulins contained in serums.
Scientists at the Wroclaw Medical University (Wroclaw, Poland) analyzed the structure of patients group according to difference between total IgG and sum of the IgG subclasses and to determine factors affecting the level of this difference. This study was based on data collected from 670 children referred to the Department of Clinical Immunology and Pediatrics in order to diagnose the immune disorders. The median age of patients was 4.2 years with 421 males (62.8%) and 249 females (37.2%).
For all children the levels of the total of immunoglobulins IgG and of the IgG subclasses (IgG1, IgG2, IgG3, and IgG4) were determined. The group of children was divided into subgroups according to gender, age (under 6 years of age, 6.5 to 12 years, and 12 to18 years), and IgG abnormality (below the normal range, normal and above the normal range). The immunoturbidimetric method utilizing the ARCHITECT cSystem was used for total IgG determination. In contrast, IgG subclass levels were measured by the nephelometric method with the use of a BN ProSpec chemistry analyzer.
The scientists found for 80 patients IgG was below the normal range, for 496 patients IgG was normal, and for 73 patients IgG was above the normal range (12.3, 76.5 and 11.2%, respectively). The group of 80 patients with Total IgG deficiency can be divided according to the medical history into three clinical subgroups: recurrent respiratory tract infections (RRT), primary immunodeficiency (PID) and transient hypogammaglobulinemia of infancy (THI). Analyzing IgG abnormality groups, it was concluded that for the population with IgG greater than IgG sum, there is a lower proportion of patients with IgG below normal range than with IgG normal or above normal range.
The authors concluded that determination of serum immunoglobulin levels is an increasingly available and relatively inexpensive laboratory test performed not only in specialized departments but also in primary care. Assessment of IgG levels as well as IgA and IgM is one of the fundamental studies on the function of the immune system. The indications for their markings are very different and primarily include diagnostics for primary and secondary immunodeficiencies. The study was published on June 27, 2018, in the journal BMC Immunology.
Related Links:
Wroclaw Medical University
Latest Clinical Chem. News
- AI-Powered Blood Test Accurately Detects Ovarian Cancer
- Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
- Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
- First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
- Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
- ‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
- Low-Cost Portable Screening Test to Transform Kidney Disease Detection
- New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
POC Diagnostic Platform Combines Immunoassay and Molecular Testing
An innovative diagnostic platform offers superior sensitivity across all sample types, including blood, compared to existing rapid tests, while maintaining a low-cost, user-friendly design.... Read more
Single Blood Test Could Detect Different Types of Cancer at Early Stages
Currently, reliable screening for only a few types of cancer is available, such as those affecting the breast, bowel, cervix (neck of the womb), and lung for individuals at high risk. While these screenings... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreMicrobiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Qiagen Acquires NGS Analysis Software Company Genoox
QIAGEN (Venlo, the Netherlands) has signed a definitive agreement to acquire Genoox (Tel Aviv, Israel), a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and... Read more
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more